Latest Insider Transactions at Johnson & Johnson (JNJ)
This section provides a real-time view of insider transactions for Johnson & Johnson (JNJ). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of JOHNSON & JOHNSON to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of JOHNSON & JOHNSON's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
73,323
+38.91%
|
$5,279,256
$72.54 P/Share
|
|
Nov 22
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Open market or private sale
|
Direct |
76,923
-37.82%
|
$13,538,448
$176.78 P/Share
|
|
Nov 22
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
BUY
Exercise of conversion of derivative security
|
Direct |
76,923
+27.44%
|
$5,538,456
$72.54 P/Share
|
|
Nov 18
2022
|
Robert J Decker VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
16,928
-52.25%
|
$2,962,400
$175.0 P/Share
|
|
Nov 18
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
16,928
+34.32%
|
$1,523,520
$90.44 P/Share
|
|
Nov 09
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Open market or private sale
|
Direct |
16,410
-18.71%
|
$2,838,930
$173.42 P/Share
|
|
Nov 09
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,410
+15.76%
|
$1,181,520
$72.54 P/Share
|
|
Nov 07
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
17,043
+13.79%
|
$1,840,644
$108.77 P/Share
|
|
Nov 04
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct |
35,246
-26.9%
|
$6,027,066
$171.18 P/Share
|
|
Nov 04
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
35,246
+21.1%
|
$4,581,980
$130.72 P/Share
|
|
Nov 02
2022
|
James D. Swanson EVP, CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,932
-35.76%
|
$676,304
$172.29 P/Share
|
|
Nov 02
2022
|
James D. Swanson EVP, CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,912
+47.41%
|
-
|
|
Oct 24
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
78,458
-0.3%
|
$13,416,318
$171.17 P/Share
|
|
Oct 24
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
78,458
+28.89%
|
$9,022,670
$115.67 P/Share
|
|
Oct 24
2022
|
William Hait EVP, Chief EI and Med Officer |
SELL
Open market or private sale
|
Direct |
15,000
-7.97%
|
$2,565,000
$171.55 P/Share
|
|
Oct 24
2022
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+13.61%
|
$1,350,000
$90.44 P/Share
|
|
Oct 19
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Open market or private sale
|
Direct |
70,126
-0.46%
|
$11,500,664
$164.5 P/Share
|
|
Oct 19
2022
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
70,126
+27.51%
|
$7,082,726
$101.87 P/Share
|
|
Jun 10
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Open market or private sale
|
Direct |
40,000
-9.48%
|
$6,920,000
$173.0 P/Share
|
|
Jun 10
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+26.44%
|
$2,880,000
$72.54 P/Share
|
|
May 26
2022
|
Robert J Decker VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
8,462
-35.35%
|
$1,523,160
$180.0 P/Share
|
|
May 26
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
8,462
+26.12%
|
$609,264
$72.54 P/Share
|
|
Apr 21
2022
|
William Hait EVP, Chief EI and Med Officer |
SELL
Open market or private sale
|
Direct |
29,699
-3.57%
|
$5,434,917
$183.58 P/Share
|
|
Apr 21
2022
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,699
+21.27%
|
$2,672,910
$90.44 P/Share
|
|
Apr 20
2022
|
Joseph J Wolk Exec VP, CFO |
SELL
Bona fide gift
|
Direct |
46
-0.06%
|
-
|
|
Mar 17
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Open market or private sale
|
Direct |
34,555
-1.63%
|
$6,081,680
$176.27 P/Share
|
|
Mar 17
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
30,785
+18.23%
|
$3,078,500
$100.97 P/Share
|
|
Mar 15
2022
|
Robert J Decker VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
5,000
-8.73%
|
$875,000
$175.51 P/Share
|
|
Mar 15
2022
|
Robert J Decker VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+19.63%
|
$360,000
$72.54 P/Share
|
|
Feb 15
2022
|
William Hait EVP, Chief EI and Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,158
-4.93%
|
$686,070
$165.89 P/Share
|
|
Feb 15
2022
|
William Hait EVP, Chief EI and Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,128
+8.78%
|
-
|
|
Feb 15
2022
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
6,209
-3.76%
|
$1,024,485
$165.89 P/Share
|
|
Feb 15
2022
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,186
+7.4%
|
-
|
|
Feb 15
2022
|
Vanessa Broadhurst EVP, Global Corp Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
925
-5.58%
|
$152,625
$165.89 P/Share
|
|
Feb 15
2022
|
Vanessa Broadhurst EVP, Global Corp Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
2,557
+13.35%
|
-
|
|
Feb 15
2022
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
12,902
-4.98%
|
$2,128,830
$165.89 P/Share
|
|
Feb 15
2022
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
29,714
+10.3%
|
-
|
|
Feb 15
2022
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
26,472
-4.33%
|
$4,367,880
$165.89 P/Share
|
|
Feb 15
2022
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
60,965
+9.06%
|
-
|
|
Feb 15
2022
|
Mathai Mammen EVP, Pharm, R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
3,366
-7.43%
|
$555,390
$165.89 P/Share
|
|
Feb 15
2022
|
Mathai Mammen EVP, Pharm, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
7,740
+14.59%
|
-
|
|
Feb 15
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
SELL
Payment of exercise price or tax liability
|
Direct |
6,242
-12.99%
|
$1,029,930
$165.89 P/Share
|
|
Feb 15
2022
|
Ashley Mc Evoy EVP, WW Chair, MedTech |
BUY
Exercise of conversion of derivative security
|
Direct |
15,806
+24.75%
|
-
|
|
Feb 15
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,699
-6.18%
|
$775,335
$165.89 P/Share
|
|
Feb 15
2022
|
Kathryn E Wengel EVP, Chief TO and Risk Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,386
+12.02%
|
-
|
|
Feb 15
2022
|
Joseph J Wolk Exec VP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,319
-16.95%
|
$1,207,635
$165.89 P/Share
|
|
Feb 15
2022
|
Joseph J Wolk Exec VP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,793
+29.18%
|
-
|
|
Feb 15
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
SELL
Payment of exercise price or tax liability
|
Direct |
1,843
-4.03%
|
$304,095
$165.89 P/Share
|
|
Feb 15
2022
|
Thibaut Mongon Exec VP, WW Chair, Cons Health |
BUY
Exercise of conversion of derivative security
|
Direct |
3,922
+7.9%
|
-
|
|
Feb 15
2022
|
Jennifer L Taubert EVP, WWC. Innovative Medicine |
SELL
Payment of exercise price or tax liability
|
Direct |
8,841
-6.53%
|
$1,458,765
$165.89 P/Share
|